Mobile-health Network Solutions
No SEC Form 4 filings for $MNDR in the last 30 days.
See all $MNDR insider activity →U.S. stocks were mixed on Monday, with the Dow up 0.4% and Nasdaq down 0.2%. Enovix (ENVX) shares surged after reporting a 38% year-over-year revenue increase to $11M. Other movers: MNDR +289%, YMAT +72%, CLWT +68%, DKI -51%, SXTC -35%, VIVK -34%. Oil rose 1.4%, gold fell 0.5%. European and Asian markets showed mixed results.
Mobile-health Network Solutions (NASDAQ: MNDR) said it developed, via subsidiary Skylink Innovations, a next-generation AI lab data analysis clinical decision-support tool under Singapore’s AI Cloud Takeoff program. The solution summarizes longitudinal lab histories, detects trends, flags abnormalities, and provides correlated diagnosis suggestions using Google Cloud AI infrastructure. The company cited faster clinician review and improved diagnostic accuracy.
MarketBeat.com compares Mobile-health Network Solutions (MNDR) and Enovis (ENOV). Enovis has a consensus target price of $44.50 (94.96% upside) and stronger analyst ratings. Enovis also has 98.4% institutional ownership and higher volatility (beta 1.41 vs MNDR -1.3). The article says Enovis leads on 11 of 13 factors.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning MNDR (Mobile-health Network Solutions). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent MNDR coverage spans financial news, earnings and technology.
Massive short‑term rally on unexpected price spike.
The article is a product-development and program-completion update, with no disclosed commercial contract, revenue, or adoption metrics.
The article frames MNDR as weaker on most factors versus ENOV, with notably higher risk/volatility relative to its own beta profile.
The company's decision to expand its 2026 Employee Incentive Plan to include Class B shares, with a cap of 15% of outstanding shares, aims to align employee and shareholder interests and improve retention. Despite this positive internal development, the stock remains underperforming with a 'Sell' rating and a $1.00 price target, indicating limited immediate positive impact on share price.
The significant after-hours price jump of Mobile-Health Network (MNDR) appears to be driven by speculative trading or possibly undisclosed news, rather than fundamental changes. The stock's low relevance score suggests limited immediate trading implications for long-term investors.
AlphAI scores every news story that mentions MNDR with an AI model for sentiment and relevance, and aggregates insider trades from Mobile-health Network Solutions's SEC EDGAR Form 4 filings. Figures refresh continuously.
U.S. stocks were mixed on Monday, with the Dow up 0.4% and Nasdaq down 0.2%. Enovix (ENVX) shares surged after reporting a 38% year-over-year revenue increase to $11M. Other movers: MNDR +289%, YMAT +72%, CLWT +68%, DKI -51%, SXTC -35%, VIVK -34%. Oil rose 1.4%, gold fell 0.5%. European and Asian markets showed mixed results.
2 min readMobile-health Network Solutions (NASDAQ: MNDR) said it developed, via subsidiary Skylink Innovations, a next-generation AI lab data analysis clinical decision-support tool under Singapore’s AI Cloud Takeoff program. The solution summarizes longitudinal lab histories, detects trends, flags abnormalities, and provides correlated diagnosis suggestions using Google Cloud AI infrastructure. The company cited faster clinician review and improved diagnostic accuracy.
3 min readMarketBeat.com compares Mobile-health Network Solutions (MNDR) and Enovis (ENOV). Enovis has a consensus target price of $44.50 (94.96% upside) and stronger analyst ratings. Enovis also has 98.4% institutional ownership and higher volatility (beta 1.41 vs MNDR -1.3). The article says Enovis leads on 11 of 13 factors.
5 min readMobile-health Network Solutions (MNDR) updated its 2025 employee incentive framework on February 6, 2026, creating a 2026 Employee Incentive Plan that now includes Class B ordinary shares. This change, capping annual equity awards at 15% of total outstanding shares, aims to better align talent and shareholder interests and strengthen retention. The company's stock currently holds a "Sell" rating with a $1.00 price target from analysts, while TipRanks' AI Analyst, Spark, rates MNDR as "Neutral" due to financial performance challenges despite strong revenue growth.
3 min readMobile-Health Network Solutions Inc. ( NASDAQ:MNDR ) shares surged 44.75% in after-hours trading on Tuesday, climbing to $2.75. Check out the current price of MNDR stock here.
2 min readMobile-Health Network Solutions ( NASDAQ:MNDR ) shares are trading higher after the company disclosed a Memorandum of Understanding ( MOU ) with PPG PP GRID SDN. BHD. The deal entails acquiring project companies developing two high-capacity, AI-optimized data centers in Sarawak, Malaysia.
3 min read
